Saama Technologies
Private Company
Total funding raised: $520M
Overview
Saama Technologies is a long-established player in the AI and digital health sector, specializing in clinical analytics for life sciences. Its core offering is a platform of AI-driven SaaS products designed to centralize data, automate manual tasks, and generate insights across clinical development and commercialization. With over a decade of focused AI research for life sciences, patented technology, and a broad suite of solutions, Saama positions itself as a leader in helping pharmaceutical and biotech companies bring therapies to market faster and more efficiently.
Technology Platform
An integrated AI-powered platform for life sciences, featuring a Clinical Data Foundation (Data Hub) with layered applications for data quality, patient/operational insights, biometrics automation (BRAIN suite), and Generative AI tools for document generation and analytics.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Saama competes in a fragmented market including large, tech-enabled CROs (IQVIA, Parexel), generic cloud/AI platforms (AWS HealthLake, Google Cloud Healthcare), and specialized clinical tech vendors (Veeva, Medidata). Its differentiation is a decade of life sciences-specific AI model training and an integrated platform built for clinical data, not adapted from other industries.